Pancrelipase Market Set to Surge by 2037
The Pancrelipase Market was valued at USD 2.3 billion in 2024 and is anticipated to surpass USD 4.1 billion by 2037 , expanding at a Compound Annual Growth Rate (CAGR) of 5% over the forecast period (2025–2037). This growth is fueled by the increasing prevalence of pancreatic exocrine insufficiency (PEI), expanding awareness of digestive enzyme therapies, and advancements in pharmaceutical formulations. Pancrelipase Industry Demand · Pancrelipase, a combination of digestive enzymes including lipase, protease, and amylase, is used to treat conditions where the pancreas fails to produce sufficient enzymes, such as cystic fibrosis, chronic pancreatitis, and other gastrointestinal disorders. · Key factors driving demand include: · Cost-effectiveness: Pancrelipase offers a reliable and economical alternative to complex surgical ...